Color, a virtual cancer clinic, announced Tuesday that it has expanded its Expert Medical Opinion services to include a new peer-to-peer program. San Francisco-based Color serves employers, health plans, unions
Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
In March, a major cyberattack hit Stryker, one of the world’s largest medical technology companies. The group that claimed responsibility, Handala, is linked to Iran, and the hackers were explicit
FDA Clears First Neurostimulation Device for PTSD
This week, Neurovalens‘ Modius Spero became the first neuromodulation device to earn FDA approval to treat PTSD. Veterans, who face disproportionately high PTSD rates, will be the first to gain
Evernorth Invests $100M for AI Specialty Pharmacy Program
Evernorth, the health services division of The Cigna Group, launched a new AI-powered program for specialty pharmacy on Thursday called Pharmacy Forward. The program is backed by a $100 million
MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Cathleen Brown, medical
Anthropic Launches Claude Science to Court Pharma Ahead of IPO
Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work. “Claude
Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’
It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals with a $1.5 billion agreement to buy the neuromuscular business
Hospitals Have Always Had Eyes — AI is Giving Them a Brain
For decades, cameras in hospital corridors were a valuable tool for capturing forensic evidence, though they were not yet the proactive security asset we see today. That model is changing
Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better
Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million acquisition of Kartos Therapeutics, a clinical-stage biotech whose lead program
4 Notable Health Tech Funding Announcements in June
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several









